Triptolide can induce the apoptosis of cisplatin-resistant ovarian most cancers cells and sensitize them to cisplatin 52. Numerous transcription factors, proteins and signaling pathways are linked to the antitumor outcomes of triptolide, but its anticancer impact is especially realized by inducing a